There are no prospective randomized controlled trials studying therapies for<unk> . Evidence for efficacy of treatments is based on many case reports and series of small groups of patients. There are case reports that non-steroidal anti-inflammatories are effective for mild disease and that corticosteroids are effective for treatment of severe<unk> . There are multiple case reports that dapsone is effective in doses from 25 mg/day to 200 mg/day. Corticosteroid-sparing medications such as azathioprine or methotrexate may be used to minimize steroid doses and limit the side effects of steroids. For severe disease cyclophosphamide is often given in addition to high dose intravenous steroids.
Relapsing polychondritis
Rheumatoid nodulosis
Reactive arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
Discoid lupus erythematosus
Polymyalgia rheumatica
Rheumatoid arthritis